title: [Laryngeal infection by Rhodococcus equi in patient with AIDS].
abstract: The Rhodococcus equi is an aerobic gram positive pleomorphic bacillus, that was isolated for the first time like a producer of bronchopneumonia in young horses. Every time more often, it is being recognized as a pathogen in humans, mainly in the immunodepressed population. We described a case, until now exceptional, of laryngeal infection by Rhodococcus equi in a patient with positive serology for the virus of the human immunodeficiency (HIV), and we reviewed some clinical and epidemiological characteristics of the infections by this germ. The treatment is riphampicine and/or erythromycin, being the prognosis bad, because usually they are immunodepressed patients.
authors.affiliation: Sección de Otorrinolaringología, Hospital de la plana, Villarreal, Castellón.
authors.forename: L
authors.initials: L
authors.lastname: Pardo Mateu
authors.forename: M
authors.initials: M
authors.lastname: Faubel Serra
authors.forename: M T
authors.initials: MT
authors.lastname: Llavero Segovia
authors.forename: B
authors.initials: B
authors.lastname: Cano Cuenca
authors.forename: F
authors.initials: F
authors.lastname: Pérez Climent
authors.forename: F
authors.initials: F
authors.lastname: Giménez Vaillo
authors.forename: E
authors.initials: E
authors.lastname: Grau Alario
authors.forename: R
authors.initials: R
authors.lastname: Lazaro Santander
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000193:Actinomycetales Infections / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007820:Laryngeal Mucosa / Q000382:microbiology / Q000473:pathology; D007827:Laryngitis / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology*; D008297:Male; D016929:Rhodococcus equi / Q000302:isolation & purification*; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D004917:Erythromycin; D012293:Rifampin